Chemical Compound

Fosamprenavir calcium

CAS Registry Number 226700-81-8

Back to search Request a Quote

Primary Record

Fosamprenavir calcium

In stock: 3,255 g
Purity: 99.5 %
CAS: 226700-81-8

Compound Identifiers & Properties

CAS: 226700-81-8
PubChem CID: 131535
SMILES: CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]
Canonical SMILES: CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]

Names & Synonyms

Fosamprenavir calcium
Lexiva
Fosamprenavir Calcium Salt
Telzir
226700-81-8
Fosamprenavircalcium
Lexiva (TN)
Telzir (TN)
Fosamprenavir calcium [USAN]
Amprenavir phosphate calcium
Fosamprenavir (Calcium Salt)
RefChem:55231
AC1L2ZCL
ID1GU2627N
UNII-ID1GU2627N
DTXSID0046777
C25H34CaN3O9PS
GW 433908G
GW433908G
C25H36N3O9PS.Ca
DTXCID8026777
Fosamprenavir calcium (USAN)
MLS006012033
GW-433908G
orb1685412
SCHEMBL1649283
CHEMBL1200734
EX-A6824A
AMY6787
MFCD08141843
PMDQGYMGQKTCSX-HQROKSDRSA-L
226700-81-8 (calcium)
Tox21_112632
CID131535
HY-17431R
VX-175
FOSAMPRENAVIR CALCIUM [MART.]
AKOS015950832
C25-H36-N3-O9-P-S.Ca
FOSAMPRENAVIR CALCIUM [WHO-DD]
CS-1411
EBC-102105
FOSAMPRENAVIR CALCIUM SALT [MI]
FOSAMPRENAVIR CALCIUM [EMA EPAR]
Fosamprenavir calcium, >=98% (HPLC)
Fosamprenavir (Calcium Salt) (Standard)
NCGC00168771-01
AC-37657
AN-16772
AS-82030
DA-73529
HY-17431
SMR004703563
SY114803
FOSAMPRENAVIR CALCIUM [ORANGE BOOK]
AB1004608
GW-433908
LS-186584
ST2419393
CAS-226700-81-8
Z4451
C74170
D03835
SBI-0654638.0001
A855875
Q27280661
Calcium (2R,3S)-1-(4-amino-N-isobutylphenylsulfonamido)-4-phenyl-3-(((((S)-tetrahydrofuran-3-yl)oxy)carbonyl)amino)butan-2-yl phosphate
calcium;[(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate
((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-(phosphonooxy)propyl)carboxamide calcium salt
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt (1:1)
(3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R)-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1)
Calcium [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonatooxy-butan-2-yl]carbamate
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt
(3S)-TETRAHYDRO-3-FURYL ((.ALPHA.S)-.ALPHA.-((1R)-1-HYDROXY-2-(N(SUP 1)-ISOBUTYLSULFANILAMIDO)ETHYL)PHENETHYL)CARBAMATE, CALCIUM PHOSPHATE (ESTER) (1:1)
(3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R)-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate, calcium phosphate (ester) (1:1)
Calcium (2R,3S)-1-(4-Amino-N-isobutylphenylsulfonamido)-4-phenyl-3-[[[[(S)-tetrahydrofuran-3-yl]oxy]carbonyl]amino]-2-butyl Phosphate
Calcium (2R,3S)-1-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-[({[(3S)-oxolan-3-yl]oxy}carbonyl)amino]-4-phenylbutan-2-yl phosphate
calcium [(1R,2S)-1-[[(4-aminophenyl)sulfonyl-isobutyl-amino]methyl]-3-phenyl-2-[[(3S)-tetrahydrofuran-3-yl]oxycarbonylamino]propyl] phosphate
calcium [(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate
Calcium(2R,3S)-1-(4-amino-N-isobutylphenylsulfonamido)-4-phenyl-3-(((((S)-tetrahydrofuran-3-yl)oxy)carbonyl)amino)butan-2-ylphosphate
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1); Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI); Fosamprenavir calcium; GW 433908G; Lexiva; GW 433908G; fosamprenavir calcium pentahydrate